- Rilonacept, sold
under the
brand name
Arcalyst, is a
medication used to
treat cryopyrin-****ociated
periodic syndromes,
including familial cold autoinflammatory...
- FDA
granted approval for
emergency use
authorization in
November 2020.
Arcalyst (rilonacept) is used for specific, rare
autoinflammatory conditions. Approved...
- antagonist, can lead to an
improvement in the
hearing loss.
Rilonacept (
Arcalyst) a
dimeric fusion protein for the
treatment of CAPS. Canakinumab, a monoclonal...
-
placarbil (USAN, INN)
arbaprostil (INN)
arbekacin (INN)
arbutamine (INN)
Arcalyst Arcet arcitumomab (INN)
arclofenin (INN)
ardacin avoparcin (INN) ardenermin...
- trap
developed by
Regeneron targeting IL-1B, and
approved in the US as
Arcalyst.
Because many
authors of
scientific m****cripts make the
minor error of...
-
February 2023. Wan Y (29
October 2009). "Canakinumab (Ilaris) and
rilonacept (
Arcalyst)
approved in EU for
treatment of cryopyrin-****ociated
periodic syndrome"...
- half-lives
through FcRn-mediated recycling. They include:
Amevive (alefacept),
Arcalyst (rilonacept),
Enbrel (etanercept),
Nplate (romiplostim),
Orencia (abatacept)...
